Insurance company Cigna is using AI to predict whether patients might abuse and/or overdose on prescription opioids in an effort to reduce consumers from using the substances, according to a report by The Wall Street Journal.

The expectation is that AI will revolutionize healthcare for patients and providers. But before AI’s potential can translate into action, several key questions must first be addressed, a recently published viewpoint argued in JAMA.

Fimmic, a Finland-based medical software company, is offering researchers and pathologists free access to its AI platform in an effort to advance the implementation of the technology in microscopic image analysis.

AI is expected to have a big impact on the way people gain access to healthcare services, according to the 2018 Health Trends report published by Stanford Medicine.

While most physicians are skeptical AI will fully replace them in the future, many do believe the technology will be able to make prognoses and overtake some administrative tasks, according to a survey of 740 general physicians in the United Kingdom.

K Health, a New York-based health technology company, raised $25 million in a recent funding round for its AI-powered health app that checks symptoms and provides information about a user’s health, according to information available on Crunchbase.

In a medical landscape where just a fraction of clinical trial participants are diverse in their race, sex, lifestyle or genetics, a team of physicians have published a paper detailing how their peers can ramp up efforts to recruit a more representative pool of patients.

The University of Guelph in Ontario, Canada, has launched a new center that aims to address the ethics of AI and build "machines with morals" by ensuring technologies benefit people and minimize harm.